Menopause and the years leading up to it (perimenopause) change where your body stores fat and how quickly it loses muscle, independent of what the scale shows. That's the main reason training and eating the same way you always have can suddenly stop 'working' the way it used to. InBody makes this invisible shift between muscle, fat and water visible and measurable over time – it isn't a diagnostic tool for menopause or hormones, though; it's an objective picture of body composition that makes most sense read alongside the rest of your health context.
Perimenopause is the multi-year transition before your final period, during which estrogen levels first fluctuate and then steadily decline. That hormonal shift changes where your body stores fat and how fast it loses muscle mass – regardless of what you weigh. The result is a paradox familiar to a lot of women in their forties and fifties: the diet and workouts stay the same, the number on the scale barely moves, but your shape, strength and energy noticeably do.
According to the large US SWAN study (Study of Women's Health Across the Nation), published in JCI Insight, the rate of fat gain roughly doubles around the menopause transition, while lean, largely muscle mass declines. These changes aren't spread evenly across a woman's life – they accelerate specifically around the transition and, per the same study, settle again roughly two years after the final period.
That's exactly why the bathroom scale is a misleading indicator during this phase. Muscle loss and fat gain can partly cancel each other out on the scale – a kilogram of muscle lost and a kilogram of fat gained show up identically in the number, even though for your health and metabolism they represent opposite trends. The number stays put while the ratio of muscle, fat and water underneath keeps shifting.
Estrogen is a hormone that, among other things, helps determine where the body stores fat and supports the maintenance of muscle mass. While estrogen levels are adequate, fat tends to be stored around the hips and thighs. As levels decline through perimenopause and menopause, that balance shifts and fat moves more toward the abdomen and around the internal organs – visceral fat. A review published in the Journal of Clinical Medicine, along with other research focused specifically on the menopause transition, links this shift partly to a relative rise in the testosterone-to-estradiol ratio after menopause.
Alongside the shift in fat, muscle mass also declines. According to expert reviews of menopause and muscle, summarized among others by The Menopause Society, falling estradiol combined with rising FSH is associated with muscle catabolism – the breakdown of muscle protein. Part of the mechanism likely runs through a mild increase in inflammatory processes in the body, which promote protein breakdown while dampening the anabolic, muscle-building pathways.
It's worth not treating these mechanisms as a fixed script that plays out identically for every woman. The speed and extent of the changes vary considerably between individuals – genetics, activity level, diet, sleep and overall health all play a role. What the research explains is why changes tend to happen faster and more often during this life stage, not exactly what will happen, or how strongly, in your specific case.
InBody is a bioelectrical impedance device that, on an InBody 970 or 970S, distinguishes muscle mass, body fat in both percentage and kilograms, visceral fat, and the ratio between different components of body water. It also reports phase angle, a general reference indicator of cellular health. All of these values can be measured repeatedly and tracked over time – exactly what a single reading on a bathroom scale can't do.
It's just as important to say what InBody doesn't measure. The device doesn't detect hormone levels – not estrogen, not FSH – and it doesn't measure bone density, so it isn't a tool for diagnosing osteoporosis. It also can't tell you whether you're already in perimenopause, in menopause, or neither – that's a question for a gynecologist, typically based on hormonal testing.
This distinction is worth stating plainly, because it's easy to mistake body composition results for the full health picture. InBody gives you an objective, measurable view of muscle, fat and water in the body – an important piece of the puzzle, not the whole picture. For the broader health context, including hormones and bone, other tests and a specialist's assessment still belong in the mix.
| Area | Area | Does InBody measure it? |
|---|---|---|
| Muscle mass (kg, by segment) | Yes | |
| Body fat (% and kg) and visceral fat | Yes | |
| Body water ratio (ECW/TBW) | Yes | |
| Phase angle as a reference indicator | Yes | |
| Estrogen and FSH levels | No | |
| Bone density and osteoporosis | No | |
| Diagnosis of menopause or hormonal status | No |
A single InBody measurement is like a photo – it captures where things stand right now but says nothing about the direction your body is heading. A series of measurements over time is more like a film: it shows the trend. In perimenopause, where changes happen gradually and often without noticeable day-to-day differences, the trend matters far more than any one number.
The trend is where you can see progress the scale can't. If muscle mass holds steady or edges up over time and visceral fat drops or at least stops climbing, even while the scale doesn't move, that's a real result of training and lifestyle – the scale alone was simply never able to capture it.
To keep the trend readable and not distorted by short-term noise, it helps to compare measurements taken under similar conditions – roughly the same time of day, similar hydration, not right after an intense workout – and at a similar interval between sessions. Short-term swings, for example around the menstrual cycle, can temporarily shift a result without reflecting any real change in body composition.
Strength training – resistance exercise with weights, bands or bodyweight – is, according to systematic reviews and meta-analyses of randomized trials published in journals such as BMC Women's Health, among the best-supported and safest interventions against the loss of strength and muscle mass associated with menopause. Women who train regularly typically show preserved or slightly increased muscle mass across these studies; the effect on fat mass itself is more variable in the research and often shows up more clearly when strength training is combined with added aerobic activity and dietary changes.
Without treating this as a medical prescription, the research generally points to consistency and gradual progression of load as the factors that matter most – the body adapting over time to slowly increasing demands, rather than any single 'magic' type of exercise. Combining strength training with adequate protein intake shows up repeatedly in the research as a sound foundation to build on.
Strength training at this life stage isn't just about appearance. Strength and muscle mass relate to functional independence in the years and decades ahead – the ability to get up from a chair, carry groceries, or keep your balance. Without promising any specific medical outcome, it's fair to say this is an investment whose effect InBody can objectively capture over time.
Hormone replacement therapy (HRT) supplies the body with hormones it's missing, primarily estrogen, in medication form. Some cohort studies, such as the Swiss OsteoLaus study published in the Journal of Clinical Endocrinology and Metabolism, have observed lower total and visceral adiposity among women using HRT compared with those who don't. That's an observational finding from specific cohorts, though, not proof that HRT changes body composition the same way for every woman.
The decision to start hormone replacement therapy is always individual and medical – it weighs far more than body composition alone, including family history, other risk factors and personal priorities. That decision belongs exclusively to a gynecologist or endocrinologist; no InBody measurement, and no body composition tracking, can replace it.
What does make sense is treating the trend in muscle, fat and visceral fat as one piece of information to discuss with your doctor when weighing next steps – not as an argument for or against therapy on its own. In that sense, objective InBody data works as a complement to professional assessment, not a substitute for it.
When reading an InBody result during perimenopause and menopause, it's worth focusing mainly on two trends: how muscle mass is moving over time, and how visceral fat is moving over time. It's also worth adding context the number alone won't capture – waist circumference, energy levels through the day, sleep quality, and how your clothes fit.
It's worth paying closer attention and consulting a specialist if muscle mass drops quickly and unexpectedly, if visceral fat keeps climbing noticeably despite regular training and a reasonable diet, or if these changes come with other symptoms – significant fatigue, sleep disruption, or cycle irregularities. In those cases, the InBody trend is a good reason to start a conversation with your doctor, not a substitute for their evaluation.
The goal of tracking body composition at this stage of life isn't to reverse menopause – no device or training plan can do that. The goal is having an objective tool that shows your effort is working, even when the bathroom scale doesn't reflect it. For a lot of women, that's exactly why they keep measuring through the period when motivation might otherwise be easiest to lose.
About the measurement
The main page about body composition measurement, result output and the visit.
More reading
FAQ
Declining estrogen changes where your body stores fat, shifting it away from the hips and thighs and toward the abdomen and around the internal organs (visceral fat). Muscle mass often declines at the same time. Because muscle loss and fat gain can partly offset each other on the scale, the number may barely move even as the ratio of fat to muscle in your body shifts noticeably.
No. InBody measures muscle mass, body fat, visceral fat and body water ratio, but it doesn't measure hormone levels like estrogen or FSH. Menopause and perimenopause can't be determined from an InBody result – that's a question for a gynecologist, usually based on hormonal testing.
According to systematic reviews and meta-analyses, strength training is one of the best-supported and safest interventions against the loss of strength and muscle mass associated with menopause. Women who train regularly typically show preserved or slightly increased muscle mass; the effect on fat mass itself is more variable and often shows up more clearly alongside added aerobic activity and dietary changes.
Yes, as a supplementary data point, not as the basis for the decision itself. You can discuss the trend in your muscle, fat and visceral fat, before and during therapy, with a gynecologist or endocrinologist. The decision about hormone replacement therapy is always individual and medical and belongs with your doctor, not with an InBody result.
The right frequency depends on your goal and how fast things are changing, but as a general guide, measuring at a consistent interval of roughly every few weeks to once a month works well – not too often, and not just sporadically. More important than exact frequency is keeping measurement conditions consistent and looking at the trend across several sessions rather than any single number.
Sources
Menopause and perimenopause change the ratio of muscle, fat and water in your body in ways that often stay invisible on a bathroom scale. An InBody measurement gives you an objective, repeatable view of how your body is actually changing over time – something you can bring to a trainer or doctor as a reliable basis for next steps. Book an InBody measurement and get your current result, and its trend over time, explained.